Resistin as an inflammatory marker in patients with schizophrenia treated with clozapine.

Abstract

BACKGROUND:

Schizophrenia is associated with excess cardiovascular comorbidity and mortality related to lifestyle factors, such as lack of physical activity, poor diet, and smoking. The prevalence of metabolic syndrome is increased among patients with schizophrenia, with the highest rates among patients on clozapine treatment. Smoking, obesity, physical inactivity, airway inflammation and obstruction, and adipose tissue and inflammatory marker activation are related in systemic inflammation. Low-grade inflammation is also associated with schizophrenia. Adipokine resistin is a biomarker involving several acute and chronic inflammatory states. However, the inflammatory role of resistin is so far inconclusive and studies in schizophrenia are scanty.

AIMS:

The aim of the present study was to explore the role of serum resistin as an inflammatory marker in patients with schizophrenia on clozapine treatment.

METHODS:

Associations between serum levels of resistin and some other selected cytokines/adipokines (adiponectin, leptin, adipsin, IL-6, IL-1Ra, TNF-α, hs-CRP) and metabolic markers in 190 patients with schizophrenia on clozapine treatment were studied using a cross-sectional study design.

RESULTS:

Among male patients especially, smokers had higher levels of resistin than non-smokers, and among smokers resistin levels were associated with IL-1Ra and hs-CRP levels. In the whole patient group levels of resistin associated with levels of IL-1Ra, and among male patients with low HDL-cholesterol.

CONCLUSIONS:

Resistin is a biomarker of systemic inflammation associated with smoking among patients with schizophrenia on clozapine treatment. Resistin might have a role as a marker of cardiovascular comorbidity.

• Authors: Jari-Pekka Klemettilä, Olli Kampman, Niko Seppälä, Merja Viikki, Mari Hämäläinen, Eeva Moilanen, Esa Leinonen
• Journal: Nordic journal of psychiatry (Nord J Psychiatry) Vol. 71 Issue 2 Pg. 89-95 (Feb 2017) ISSN: 1502-4725 [Electronic] England
• PMID: 27658459 (Publication Type: Journal Article)

Chemical References

• Antipsychotic Agents
• Biomarkers
• RETN protein, human
• Resistin
• Clozapine

Topics

• Adult
• Aged
• Antipsychotic Agents (therapeutic use)
• Biomarkers (blood)
• Clozapine (therapeutic use)
• Cross-Sectional Studies
• Female
• Humans
• Inflammation (blood)
• Male
• Middle Aged
• Resistin (blood)
• Schizophrenia (blood, drug therapy)
• Smoking (blood)
• Young Adult